Research and Funding

Reubin Andres, early leader in aging research, dies

January 24, 2013


Reubin Andres

Dr. Reubin Andres, an early leader in the field of aging research and the first clinical director of NIA, died on September 23, 2012. “I was saddened to hear the news of Dr. Andres’s passing. His legacy will most certainly be his dedication and vision in research on aging. Dr. Reubin was a true pioneer, a valued mentor and colleague and a marvelous human being,” said NIA Director Dr. Richard J. Hodes.

Dr. Andres joined the Gerontology Research Center (the precursor to NIA) in 1962, where he was assistant chief and head of the GRC’s metabolism section. He was later named the first clinical director of NIA, serving in this position from 1977 until 1998.

Dr. Andres was named an NIH scientist emeritus at the time of his retirement in 2003. He was cited for his productive research career that included the invention of the glucose insulin clamp technique, a method that remains the gold standard in the study of glucose and insulin homeostasis in man; his original and fundamental observations on the hormonal abnormalities in diabetes mellitus; and his recognition that mortality follows a U-shaped curve as a function of body mass index with the minimal mortality/maximal longevity associated with higher body mass index than prior work suggested.

Among his many achievements, Dr. Andres played a critical role in the development of the Baltimore Longitudinal Study of Aging, now in its 54th year. “With the passing of Dr. Andres, we’ve lost a great man and an extraordinarily talented and generous scientist. I’m sure that his name will continue to inspire generations of researchers in aging for years to come,” said NIA Scientific Director Dr. Luigi Ferrucci.

Share this:
Email Twitter Linkedin Facebook